CRYOSITE LIMITED (CTE)

---

AI Coverage Rating: Active

ASX AI Signals has generated 3 signal for CTE during the last 90 days, indicating active trading activity and ongoing AI monitoring

Latest CTE Signals
11/05/2026	SELL
10/05/2026	SELL
09/05/2026	SELL
CTE Share Price
Current Price	$1.250
52 Week High	$1.300
52 Week Low:	$0.660
Trading at (% of 52 Week High)	96.15%

Business Overview

Cryosite Limited (ASX: CTE) is an Australian company specializing in the development and supply of cryogenic equipment and services. The company focuses on providing advanced solutions for freezing and storage technologies used in various industries such as medical, scientific, and industrial sectors.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The SELL recommendation for CRYOSITE LIMITED (CTE) is supported by technical indicators and market sentiment suggesting downward pressure. However, the moderate liquidity and potential volatility in the stock price introduce some uncertainty.

Latest  CRYOSITE LIMITED(CTE)   News